Aromasin side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Aromasin. Common side effects include arthralgia among females, and amnesia among males.
The phase IV clinical study is created by eHealthMe based on 12,312 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
12,312 people who take Aromasin and have side effects are studied.
What is Aromasin?
Aromasin has active ingredients of exemestane. It is used in breast cancer. Currently, eHealthMe is studying from 12,551 Aromasin users.
Number of Aromasin reports submitted per year:
Aromasin side effects by time on the drug *:
Aromasin side effects by gender *:
Aromasin side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Aromasin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on exemestane (the active ingredients of Aromasin) and Aromasin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Aromasin:
- Aromasin (12,551 reports)
Common Aromasin side effects:
- Fatigue (feeling of tiredness): 1,365 reports
- Pain: 1,251 reports
- Joint pain: 1,214 reports
- Weakness: 904 reports
- Stress and anxiety: 899 reports
- Breathing difficulty: 889 reports
All Aromasin side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chlor-Trimeton and Insulin drug interaction - 2 seconds ago
- Tramadol and Thrombotic Microangiopathy - 10 seconds ago
- Incivek and Vitamin B drug interaction - 11 seconds ago
- Pyrazinamide and Aldactone drug interaction - 11 seconds ago
- Aminocaproic and Fenofibrate drug interaction - 14 seconds ago
- Viread and Depakote drug interaction - 28 seconds ago
- Stivarga and Flonase Allergy Relief drug interaction - 28 seconds ago
- Provigil and Hyzaar drug interaction - 35 seconds ago
- Tasigna and Neutrophil Count Decreased - 46 seconds ago
- Prilosec and Skin Burning Sensation - a minute ago